Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × Topotecan × Clear all

Sponsor

Conditions

Ovarian Neoplasms 26 Small Cell Lung Carcinoma 21 Neuroblastoma 12 Fallopian Tube Neoplasms 12 Uterine Cervical Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Lung Neoplasms 6 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Leukemia, Myeloid, Acute 3 Ganglioneuroblastoma 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Small Cell 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Retinoblastoma 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peritoneal Neoplasms 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 7 X-Rays 5 Phantoms, Imaging 5 Bevacizumab 5 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Carboplatin 3 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 Vemurafenib 2 Lapatinib 2 LY3023414 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 veliparib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 marizomib 1 imetelstat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡